Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0CI9W
|
||||
Former ID |
DIB016364
|
||||
Drug Name |
GSK-334429
|
||||
Synonyms |
GSK-334429; GSK-357868; GSK-678103; H3 antagonists (cognitive disorder); H3 antagonists (cognitive disorder), GlaxoSmithKline
|
||||
Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Investigative | [543673] | ||
Company |
GlaxoSmithKline plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
N1(CCN(CCC1)C(=O)C1CCN(CC1)c1cnc(cc1)C(F)(F)F)C(C)C
|
||||
Target and Pathway | |||||
Target(s) | Histamine H3 receptor | Target Info | Antagonist | [543673] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.